May 28 2025
A standardized cannabis extract significantly reduces inflammation in human skin cells—more effectively than CBD alone—according to a new study published in Pharmaceuticals. Researchers from Università degli Studi di Milano in Italy and Linnea SA in Switzerland analyzed the effects of a Cannabis sativa extract (CSE) with 5% CBD and less than 0.2% THC on human …
May 28 2025
A new study conducted at the University of Washington suggests that young adults in Washington State may be reducing their cannabis use earlier than in years past, despite increased legalization and availability. Analyzing data from 15,371 individuals ages 18 to 25 collected across a seven-year period, researchers found that cannabis use peaked at ages 21 …
May 27 2025
Women with anorexia experienced a resurfacing of previously blocked traumatic memories during psilocybin-assisted therapy, leading to remission of their eating disorder symptoms, according to a new study published in the Journal of Eating Disorders. The pilot study involved 10 women diagnosed with anorexia nervosa or in partial remission. Each received a 25-mg dose of COMP360, …
May 27 2025
A new study published in BMC Genomics explores how different parts of the marijuana plant influence the production of cannabinoids and terpenes, offering insight into the plant’s internal regulatory mechanisms. Through a comprehensive transcriptomic analysis of wild cannabis, researchers identified over 2,500 differentially expressed genes (DEGs) across leaf, stem, and root tissues. These findings point …
May 27 2025
A study published in the International Journal of Pharmaceutics suggests that combining cannabinoid and terpene nanoparticles could offer enhanced pain-relief effects while requiring lower doses. For the study, researchers encapsulated cannabigerolic acid (CBGA) and three cannabis-derived terpenes—myrcene, nerolidol, and caryophyllene—into biodegradable nanoparticles, then tested them alone and in combination for their ability to activate the …
May 26 2025
New research published in the journal Frontiers in Aging Neuroscience finds that daily cannabidiol (CBD) treatment may help slow cognitive decline in aging, without impairing motor skills or causing negative side effects. Researchers from the University of Lethbridge and McGill University studied the impact of CBD in an animal model over a seven-month period. Starting …
May 26 2025
Researchers from Université Laval in Quebec have mapped key genetic markers responsible for cannabinoid production in marijuana, a discovery they say could revolutionize strain development and genetic selection in the legal cannabis industry. The findings were published in Plant Genome. Using a genome-wide association study (GWAS) on 174 marijuana strains from Canada’s legal market, the …
May 25 2025
According to a new study, researchers have developed a 3D-printed stent designed to treat urinary tract infections (UTIs) using cannabidiol (CBD), potentially offering a targeted alternative to conventional antibiotic therapy. The study, published in the International Journal of Pharmaceutics, was conducted by scientists from the University of Bern in Switzerland and the University of Rome …
May 24 2025
A new study published in Neuropharmacology suggests that even a very low dose of cannabidiol (CBD) may be enough to partially reverse symptoms of depression brought on by chronic stress. Researchers from the Universitat de Barcelona and the University of Greifswald used a well-established mouse model of Major Depressive Disorder (MDD) to examine the effects …
May 24 2025
A new double-blind, placebo-controlled crossover study has found that cannabidiol (CBD) led to behavioral improvements in about two-thirds of boys with autism spectrum disorder, though researchers emphasize that a strong placebo effect complicates interpretation of the results. Conducted by the University of California San Diego School of Medicine and published in the Journal of Autism …
